Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis bulks up in immuno-oncology with a $750M Aduro deal
Novartis bulks up in immuno-oncology with a $750M Aduro deal
Novartis bulks up in immuno-oncology with a $750M Aduro deal
Submitted by
admin
on March 30, 2015 - 9:57am
Source:
Fierce Biotech
News Tags:
Novartis
Aduro BioTech
immuno-oncology
Headline:
Novartis bulks up in immuno-oncology with a $750M Aduro deal
Do Not Allow Advertisers to Use My Personal information